Five Candidate Genes Mark an Anesthesia-Linked Microglial Program
A transcriptomic search for anesthesia-related neuroimmune signals has converged on five candidate hub genes: Fibin, Scaf1, Plcb2, Kcnh4, and Ptprj. The signal came from a rat basolateral amygdala dataset exposed to isoflurane, then was cross-checked against single-cell microglial data, multi-dataset expression comparisons, and a propofol-treated BV2 model. The study frames these genes as candidate molecular correlates of anesthesia-associated microglial transcriptional change, not as validated biomarkers of perioperative neurocognitive disorder.
The distinction matters because no cognitive endpoint, delirium model, or PND phenotype was measured. The work instead maps a plausible inflammatory transcriptional route through microglia, a cell type that sits at the center of neuroimmune surveillance and can switch rapidly toward pro-inflammatory behavior after anesthetic exposure.
Small Discovery Cohort, Large Analytical Ambition
The discovery set was modest: six rat amygdala samples in GSE1779, with three controls and three isoflurane-exposed animals. Differential expression analysis yielded 58 altered genes, and LASSO regression narrowed the field to a five-gene candidate panel. Because the training cohort was so small, the cross-validation process functioned more like an approximate leave-one-out exercise than a stable penalized model fit, and coefficient estimates carry clear uncertainty.
Even so, the resulting gene set is biologically coherent. Plcb2 sits within phospholipase signaling and calcium-linked immune activation; Ptprj is tied to receptor-type protein tyrosine phosphatase signaling; Kcnh4 points toward ion-channel biology; Scaf1 suggests scaffolded intracellular signaling; and Fibin has emerged in other transcriptional contexts as a developmentally and structurally relevant gene. The analysis does not prove causality, but it does nominate a compact molecular fingerprint for follow-up.
Microglial Subcluster MG1 Carries the Pro-Inflammatory Signal
Single-cell RNA sequencing from GSE217202 added a cell-type layer to the bulk-tissue findings. Among 9,451 microglial profiles, the analysis resolved a microglial subcluster designated MG1 as the transcriptionally pro-inflammatory state. Each hub gene defined a distinct molecular program within that cell population, suggesting that anesthesia does not produce a single flat inflammatory response but rather pushes microglia into separable transcriptional tracks.
One direct bedside implication follows from that architecture. Anesthetic exposure may not simply “activate microglia” in a uniform way; it may bias the cells toward specific regulatory states, each with its own signaling logic and potential therapeutic vulnerability.
The pseudotime analysis supported a weak cell-level association between Plcb2 expression and the MG1 state, with ρ = −0.061. That correlation is descriptive rather than persuasive, but it fits the broader picture of a transcriptional transition from homeostatic microglia toward a more inflammatory condition. In practical terms, the trajectory analysis is useful as a map, not as proof of directionality.
Directionality Was Not Uniform Across Datasets
Cross-dataset comparison exposed heterogeneity rather than a single universal pattern. Fibin rose significantly in GSE1779 and GSE106799, while Ptprj fell significantly in GSE1779. The study also included five GEO datasets spanning two species and three anesthetic agents, and that breadth makes one point unmistakable: anesthesia-related transcriptional responses are context-dependent.
Different anesthetics can engage overlapping but nonidentical neuroimmune pathways. Volatile agents and intravenous agents may converge on inflammatory readouts while still producing different gene-level signatures, depending on dose, exposure duration, species, and tissue context. This is one reason the authors framed the five genes as candidate correlates rather than a validated universal panel.
Mef2c and Rel Emerged as Candidate Regulators
SCENIC inference pointed to Mef2c and the NF-κB component Rel as candidate upstream regulators. The biology is plausible. NF-κB signaling is a classic inflammatory switch, and its engagement aligns with the observed pro-inflammatory transcriptional state. Mef2c, in contrast, may reflect a more nuanced regulatory layer that helps shape microglial identity and state transitions rather than acting as a simple on-off inflammatory trigger.
The regulatory inference was computational, not experimental, so it should be treated as a hypothesis generator. Still, placing Rel upstream of these changes fits with the broader literature linking anesthetic exposure, innate immune activation, and microglial polarization toward inflammatory phenotypes.
Propofol-Treated BV2 Cells Reinforced the Inflammatory Direction
The in vitro arm used propofol-treated BV2 microglia exposed to 30 μM propofol for 4 to 12 hours. In that model, Scaf1 and Plcb2 mRNA increased, while iNOS and phospho-NF-κB protein expression also rose. The response supports an inflammatory shift, at least in this transformed cell line and under the conditions tested.
Cell-line confirmation is not equivalent to primary-microglia biology or in vivo anesthesia exposure. BV2 cells can be useful for directional validation, but they do not reproduce the full cellular ecology of the brain, where neurons, astrocytes, endothelial cells, peripheral immune traffic, and regional circuitry all shape the final response.
The signal is still informative. Propofol, often discussed as a clinically standard anesthetic, may intersect with inflammatory pathways in ways that depend on exposure context and model system. A rise in phospho-NF-κB after propofol treatment gives mechanistic weight to the idea that anesthetic agents can participate in transcriptional reprogramming of microglia.
Why This Matters for Perioperative Neurocognitive Research
Perioperative neurocognitive disorder remains a clinical concern because cognitive decline after surgery can affect recovery, independence, and long-term quality of life. This study does not establish a direct link between the five candidate genes and PND. It does, however, identify a molecular route that could be tested in more clinically relevant systems built around cognition, memory, and behavior.
The amygdala focus also deserves attention. Although PND is often discussed through hippocampal or cortical frameworks, the amygdala contributes to emotional processing, stress biology, and broader network coordination. In that setting, anesthesia-associated microglial changes may influence more than memory alone.
Validation Still Defines the Next Step
The most important constraints are already visible in the methods. The discovery cohort was tiny, the single-cell dataset had only one sample per condition, and the external expression patterns were not uniform. Sex-specific inference is also limited because the rat discovery samples came from males. Together, those features leave the study in an exploratory lane.
Future work needs primary microglia, in vivo intervention studies, and cognition-linked models before any diagnostic or therapeutic claim can be made. The current data identify Fibin, Scaf1, Plcb2, Kcnh4, and Ptprj as candidate molecular correlates of anesthesia-associated microglial transcriptional change, with Mef2c and Rel as inferred regulators. Whether those signals survive in a clinically meaningful PND framework remains untested.